Canon upgrades its PET/CT system

Canon Medical Systems (NYSE:CAJ)  said it is rolling out enhancements to its Celesteion PET/CT system.

The new software, which is available for new and existing Celesteion PET/CT systems, includes a  range of new acquisition and reconstruction techniques. The new acquisition techniques include:

• Variable bed time (vBT), designed to enable clinicians to adjust scan times and acquisition mode per bed position for optimal results, including faster exams.
• PET respiratory gating, which incorporates respiratory gating into whole-body PET scans to help avoid extra scans, reduce dose while improving patient experience, and improve workflow efficiency.
• PET ECG gated scanning, designed to offer clinicians the ability to perform PET ECG phase image reconstruction scans.

The new reconstruction techniques are:

• • Clear adaptive low-noise method (CaLM) +PSF, designed to deliver improved PET image quality by filtering out noise while maintaining contrast, and offer greater clarity while preserving detail in the image as compared to local means filtering.
  • Single-energy metal artifact reduction (SEMAR), which uses a reconstruction technique to reduce metallic artifact, improve visualization of implants, and support bone and the adjacent soft tissues for a clearer image.

“The new software enhancements are our way of delivering fresh, innovative solutions to help our customers further improve workflow and image quality on a system that is known for delivering a more comfortable patient experience,” said Dominic Smith, senior director of Canon Medical Systems’ CT, PET/CT, and MR business units, in a prepared statement.

Canon acquired Toshiba Medical Systems (Tustin, Calif.) in 2016 and changed the name to Canon Medical Systems in 2018.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW